Esketamine (Spravato)

esketamine · Janssen Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Esketamine (Spravato), covering 2025-04-27 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Dexmedetomidine-esketamine Combination and Chronic Postsurgical Pain After Spinal Surgery [Phase 4]